Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down on greenhouse emissions and create a solution that is more eco ...

The grant was part of the country’s move to support the development and production of inhalers that utilize new propellants with lower global warming potential.